HOLX

MKT CAP:$17B

Hologic, Inc.

Market Cap

$17B

Healthcare·Medical - Instruments & Supplies·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$76.01+$1.45 (+1.94%)

Apr 7, 2026

Company Details

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internation...

CEO

Stephen MacMillan

IPO Date

Mar 1, 1990

Website

www.hologic.com

Key Metrics TTM

Revenue

$4.1B

+2.2% YoY

Net Income

$544M

EPS (Diluted)

$2.40

Free Cash Flow

$1000M

Revenue / Share

$18.27

Gross Margin

52.8%

Operating Margin

17.5%

Net Margin

13.2%

FCF Margin

24.2%

P/S

4.1x

P/E

31.2x

Earnings Reports

Q2 2026

May 7, 2026

PENDING

Q1 2026

Jan 29, 2026

$1.0B+2.5%EPS $0.79

FY 2025

Nov 18, 2025

$4.1B+1.7%EPS $2.49

Q4 2025

Nov 18, 2025

$1.0B+6.2%EPS $0.83

Q3 2025

Jul 31, 2025

$1.0B+1.2%EPS $0.86

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q2 22	$1.4B	$947M	$594M
Q3 22	$1.0B	$550M	$264M
Q4 22	$953M	$515M	$141M
Q1 23	$1.1B	$618M	$262M
Q2 23	$1.0B	$586M	$272M
Q3 23	$984M	$368M	$1M
Q4 23	$945M	$500M	$133M
Q1 24	$1.0B	$568M	$198M
Q2 24	$1.0B	$563M	$243M
Q3 24	$1.0B	$560M	$244M
Q4 24	$988M	$558M	$230M
Q1 25	$1.0B	$581M	$230M
Q2 25	$1.0B	$377M	-$7M
Q3 25	$1.0B	$577M	$255M
Q4 25	$1.0B	$639M	$237M
Q1 26	$1.0B	$586M	$237M

Valuation

Quarter	P/S	P/E
Q2 22	3.1x	10.9x
Q3 22	3.2x	11.2x
Q4 22	3.5x	13.0x
Q1 23	3.8x	17.1x
Q2 23	4.2x	22.5x
Q3 23	4.2x	35.1x
Q4 23	4.2x	37.2x
Q1 24	4.3x	32.9x
Q2 24	4.3x	36.4x
Q3 24	4.3x	24.2x
Q4 24	4.2x	21.5x
Q1 25	4.2x	22.8x
Q2 25	4.2x	30.5x
Q3 25	4.2x	30.5x
Q4 25	4.1x	30.0x
Q1 26	4.1x	31.2x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q2 22	$1.1B	$1.0B
Q3 22	$331M	$305M
Q4 22	$169M	$137M
Q1 23	$253M	$224M
Q2 23	$206M	$174M
Q3 23	$333M	$296M
Q4 23	$259M	$206M
Q1 24	$220M	$182M
Q2 24	$292M	$264M
Q3 24	$406M	$372M
Q4 24	$367M	$337M
Q1 25	$189M	$142M
Q2 25	$169M	$129M
Q3 25	$343M	$331M
Q4 25	$355M	$325M
Q1 26	$230M	$215M

Capital Expenditures

Quarter	CapEx
Q2 22	$54M
Q3 22	$26M
Q4 22	$32M
Q1 23	$29M
Q2 23	$32M
Q3 23	$37M
Q4 23	$53M
Q1 24	$38M
Q2 24	$28M
Q3 24	$34M
Q4 24	$30M
Q1 25	$47M
Q2 25	$40M
Q3 25	$13M
Q4 25	$30M
Q1 26	$15M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q2 22	-6.6%	+13.6%
Q3 22	-14.2%	-8.8%
Q4 22	-27.6%	-7.4%
Q1 23	-27.0%	-2.2%
Q2 23	-28.5%	-10.4%
Q3 23	-1.8%	+33.1%
Q4 23	-0.8%	+0.1%
Q1 24	-5.7%	+0.4%
Q2 24	-0.8%	+2.7%
Q3 24	+2.7%	-21.9%
Q4 24	+4.5%	-6.7%
Q1 25	+0.9%	-2.8%
Q2 25	-1.2%	+30.7%
Q3 25	+1.2%	+0.2%
Q4 25	+6.2%	+7.2%
Q1 26	+2.5%	+2.4%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q2 22	$18M	1.2%
Q3 22	$15M	1.5%
Q4 22	$15M	1.6%
Q1 23	$21M	1.9%
Q2 23	$23M	2.3%
Q3 23	$17M	1.7%
Q4 23	$19M	2.0%
Q1 24	$29M	2.8%
Q2 24	$26M	2.5%
Q3 24	$15M	1.4%
Q4 24	$13M	1.3%
Q1 25	$30M	2.9%
Q2 25	$28M	2.8%
Q3 25	$14M	1.3%
Q4 25	$12M	1.2%
Q1 26	$27M	2.6%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q2 22	$70M	$101M	$171M
Q3 22	$65M	$92M	$152M
Q4 22	$76M	$97M	$159M
Q1 23	$75M	$109M	$164M
Q2 23	$74M	$101M	$142M
Q3 23	$73M	$90M	$150M
Q4 23	$73M	$93M	$140M
Q1 24	$67M	$112M	$149M
Q2 24	$75M	$100M	$144M
Q3 24	$64M	$94M	$146M
Q4 24	$67M	$103M	$146M
Q1 25	$60M	$116M	$166M
Q2 25	$62M	$120M	$154M
Q3 25	$61M	$99M	$152M
Q4 25	$65M	$115M	$148M
Q1 26	$61M	$128M	$155M

Revenue Segments

Quarter	Capital Equipment, Components and Software	Consumables	Other Type of Revenue	Service	Breast Health	Diagnostics	Gyn Surgical	Skeletal Health
Q2 22	$157M	$1.1B	$5M	$163M	—	—	—	—
Q3 22	$124M	$713M	$5M	$161M	—	—	—	—
Q1 23	$159M	$728M	$5M	$183M	—	—	—	—
Q2 23	$211M	$627M	$6M	$183M	—	—	—	—
Q3 23	$190M	$609M	$5M	$180M	—	—	—	—
Q4 23	$181M	$576M	$4M	$184M	—	—	—	—
Q1 24	$199M	$629M	$6M	$179M	—	—	—	—
Q2 24	$209M	$619M	$5M	$185M	—	—	—	—
Q3 24	—	—	—	—	$385M	$441M	$167M	$19M
Q1 25	—	—	—	—	$369M	$471M	$166M	$16M
Q2 25	—	—	—	—	$356M	$454M	$163M	$33M
Q3 25	—	—	—	—	$365M	$449M	$178M	$31M
Q4 25	—	—	—	—	$394M	$454M	$173M	$29M
Q1 26	—	—	—	—	$376M	$464M	$181M	$27M

Revenue by Geography

Quarter	Asia-Pacific	Europe	Rest of World	United States
Q2 22	$110M	$291M	$42M	$992M
Q3 22	$72M	$165M	$32M	$735M
Q1 23	$64M	$147M	$39M	$824M
Q2 23	$65M	$152M	$41M	$769M
Q3 23	$63M	$129M	$43M	$750M
Q4 23	$64M	$93M	$73M	$716M
Q1 24	$64M	$143M	$53M	$754M
Q2 24	$64M	$137M	$57M	$759M
Q3 24	$65M	$128M	$53M	$765M
Q1 25	$60M	$149M	$55M	$758M
Q2 25	$60M	$147M	$54M	$745M
Q3 25	$60M	$148M	$55M	$761M

War Chest

Quarter	Cash	Short-term Investments	Total
Q2 22	$2.3B	$0	$2.3B
Q3 22	$2.4B	$0	$2.4B
Q4 22	$2.3B	$0	$2.3B
Q1 23	$2.4B	$0	$2.4B
Q2 23	$2.6B	$0	$2.6B
Q3 23	$2.8B	$0	$2.8B
Q4 23	$2.7B	$0	$2.7B
Q1 24	$1.9B	$0	$1.9B
Q2 24	$2.2B	$0	$2.2B
Q3 24	$2.4B	$0	$2.4B
Q4 24	$2.2B	$173M	$2.3B
Q1 25	$1.8B	$191M	$2.0B
Q2 25	$1.4B	$192M	$1.6B
Q3 25	$1.7B	$144M	$1.9B
Q4 25	$2.0B	$243M	$2.2B
Q1 26	$2.2B	$197M	$2.4B

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q2 22	254M	-0.9%	-2.7%
Q3 22	253M	-0.2%	-2.1%
Q4 22	253M	-0.2%	-2.0%
Q1 23	249M	-1.3%	-2.7%
Q2 23	250M	+0.2%	-1.5%
Q3 23	247M	-1.2%	-2.4%
Q4 23	247M	+0.1%	-2.1%
Q1 24	240M	-2.8%	-3.6%
Q2 24	238M	-1.1%	-4.9%
Q3 24	236M	-0.5%	-4.2%
Q4 24	236M	-0.2%	-4.5%
Q1 25	232M	-1.6%	-3.4%
Q2 25	226M	-2.7%	-5.0%
Q3 25	225M	-0.1%	-4.7%
Q4 25	226M	+0.1%	-4.3%
Q1 26	226M	+0.1%	-2.7%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q2 22	$214.1K	7K
Q3 22	$149.5K	7K
Q4 22	$137.3K	7K
Q1 23	$154.7K	7K
Q2 23	$147.8K	7K
Q3 23	$141.8K	7K
Q4 23	$135.2K	7K
Q1 24	$144.9K	7K
Q2 24	$145.6K	7K
Q3 24	$144.7K	7K
Q4 24	$139.9K	7K
Q1 25	$144.7K	7K
Q2 25	$142.3K	7K
Q3 25	$145.0K	7K
Q4 25	$148.4K	7K
Q1 26	$148.2K	7K

Revenue / Employee